FdaApplication
NDA 219616
Identifiers
- fda_app_no: NDA219616
Properties
| Property | Value |
|---|---|
| applicant_name | VERASTEM INC |
| application_type | NDA |
| approval_date | 2025-05-08 |
Revenue by product
AVMAPKI FAKZYNJA CO-PACK (COPACKAGED)
| Period | Revenue |
|---|---|
| Q2 2024 | $10.0M*† |
Revenue as this company reported it for this product. A combination product's amount is stated once, for the product, and never divided across its ingredients. A figure marked † is the company's one reported revenue line rather than a product breakdown.
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| AVMAPKI FAKZYNJA CO-PACK (COPACKAGED) | AVUTOMETINIB POTASSIUM; DEFACTINIB HYDROCHLORIDE | EQ 0.8MG BASE;EQ 200MG BASE | CAPSULE, TABLET;ORAL |
1 product